PEEL-224 Clinical Trials
3 recruitingDrug
Phase 13Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Refractory NeuroblastomaRefractory RhabdomyosarcomaRefractory Solid Tumors+3 more
Theodore Laetsch59 enrolled7 locationsNCT06721689
Recruiting
Phase 1Phase 2
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
SarcomaOsteosarcomaRhabdomyosarcoma+3 more
David S Shulman, MD63 enrolled3 locationsNCT06709495
Recruiting
Phase 1
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Peel Therapeutics Inc65 enrolled7 locationsNCT05329103